Drug Shortage Report for BENZACLIN
Report ID | 205401 |
Drug Identification Number | 02248472 |
Brand name | BENZACLIN |
Common or Proper name | BENZACLIN |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | BENZOYL PEROXIDE CLINDAMYCIN |
Strength(s) | 5% 1% |
Dosage form(s) | GEL |
Route of administration | TOPICAL TOPICAL |
Packaging size | 50g |
ATC code | D10AF |
ATC description | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-09-25 |
Estimated end date | 2023-10-04 |
Actual end date | 2023-10-03 |
Shortage status | Resolved |
Updated date | 2023-10-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-10-06 | French | Compare |
v3 | 2023-10-06 | English | Compare |
v2 | 2023-09-28 | French | Compare |
v1 | 2023-09-28 | English | Compare |
Showing 1 to 4 of 4